Compare WYETH LTD with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs ORCHID PHARMA LTD - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD ORCHID PHARMA LTD WYETH LTD/
ORCHID PHARMA LTD
 
P/E (TTM) x 27.7 -0.4 - View Chart
P/BV x 5.3 0.1 4,541.5% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 WYETH LTD   ORCHID PHARMA LTD
EQUITY SHARE DATA
    WYETH LTD
Mar-13
ORCHID PHARMA LTD
Sep-13
WYETH LTD/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs1,044194 538.4%   
Low Rs81835 2,337.1%   
Sales per share (Unadj.) Rs298.6276.5 108.0%  
Earnings per share (Unadj.) Rs57.2-79.2 -72.3%  
Cash flow per share (Unadj.) Rs58.4-43.5 -134.4%  
Dividends per share (Unadj.) Rs17.000-  
Dividend yield (eoy) %1.80-  
Book value per share (Unadj.) Rs249.553.9 462.5%  
Shares outstanding (eoy) m22.7270.45 32.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.10.4 753.1%   
Avg P/E ratio x16.3-1.4 -1,125.4%  
P/CF ratio (eoy) x15.9-2.6 -605.0%  
Price / Book Value ratio x3.72.1 175.8%  
Dividend payout %29.70-   
Avg Mkt Cap Rs m21,1578,067 262.3%   
No. of employees `0000.52.8 17.6%   
Total wages/salary Rs m4002,527 15.8%   
Avg. sales/employee Rs Th13,787.46,956.1 198.2%   
Avg. wages/employee Rs Th813.0902.5 90.1%   
Avg. net profit/employee Rs Th2,643.3-1,993.0 -132.6%   
INCOME DATA
Net Sales Rs m6,78319,477 34.8%  
Other income Rs m353407 86.6%   
Total revenues Rs m7,13619,884 35.9%   
Gross profit Rs m1,6171,103 146.7%  
Depreciation Rs m272,519 1.1%   
Interest Rs m65,227 0.1%   
Profit before tax Rs m1,938-6,236 -31.1%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5511 -1.0%   
Tax Rs m632-125 -505.0%   
Profit after tax Rs m1,301-5,580 -23.3%  
Gross profit margin %23.85.7 421.2%  
Effective tax rate %32.62.0 1,625.0%   
Net profit margin %19.2-28.7 -66.9%  
BALANCE SHEET DATA
Current assets Rs m6,98411,014 63.4%   
Current liabilities Rs m2,05632,060 6.4%   
Net working cap to sales %72.6-108.1 -67.2%  
Current ratio x3.40.3 988.8%  
Inventory Days Days9995 104.6%  
Debtors Days Days2434 71.3%  
Net fixed assets Rs m24429,440 0.8%   
Share capital Rs m227705 32.2%   
"Free" reserves Rs m5,4412,043 266.4%   
Net worth Rs m5,6683,800 149.2%   
Long term debt Rs m259,018 0.3%   
Total assets Rs m7,90146,510 17.0%  
Interest coverage x353.3-0.2 -182,957.3%   
Debt to equity ratio x02.4 0.2%  
Sales to assets ratio x0.90.4 205.0%   
Return on assets %16.5-0.8 -2,174.8%  
Return on equity %22.9-146.9 -15.6%  
Return on capital %34.0-3.7 -911.6%  
Exports to sales %0.237.9 0.6%   
Imports to sales %36.322.6 160.7%   
Exports (fob) Rs m157,378 0.2%   
Imports (cif) Rs m2,4654,406 56.0%   
Fx inflow Rs m157,513 0.2%   
Fx outflow Rs m2,6775,649 47.4%   
Net fx Rs m-2,6621,865 -142.8%   
CASH FLOW
From Operations Rs m9231,682 54.9%  
From Investments Rs m317-9,860 -3.2%  
From Financial Activity Rs m-4816,644 -7.2%  
Net Cashflow Rs m759-1,535 -49.5%  

Share Holding

Indian Promoters % 0.0 32.3 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 4.6 245.7%  
FIIs % 7.2 3.3 218.2%  
ADR/GDR % 0.0 4.6 -  
Free float % 30.4 55.3 55.0%  
Shareholders   21,978 84,811 25.9%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   PANACEA BIOTECH  BIOCON   J.B.CHEMICALS  NATCO PHARMA  DIVIS LABORATORIES  

Compare WYETH LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Slow Economy? There's Still Good Money to Be Made in the Markets(Podcast)

Indian stock markets mostly remained in the negative zone during the week except for Wednesday.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks(Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years)(Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Here's Why I Recommended 15 Stocks in One Day Flat(Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

Will Algo Traders Take Away All Your Profits?(Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

These Rebirth of India Stocks Are Raring to Compete with Tesla(The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS